Results 111 to 120 of about 3,624 (175)

Modified Hevein-like Peptide from <i>Amaranthus caudatus</i> as a Promising Agent Against Pathogenic <i>Candida</i> Species. [PDF]

Pharmaceutics
Finkina EI, Gerasimova AA, Shevchenko OV, Bogdanov IV, Tagaev AA, Voropaev AD, Ovchinnikova TV.   +6 more
europepmc   +1 more source

Organoselenium Compounds Derived from Natural Metabolites. [PDF]

Pharmaceuticals (Basel)
Pacuła-Miszewska AJ, Obieziurska-Fabisiak M, Ścianowski J.   +2 more
europepmc   +1 more source

Identification of Plasma-Generated Reactive Species in Water and Their DNA-Damaging Effects on Plasmid and Lymphocyte DNA. [PDF]

Int J Mol Sci
Kyzek S, Pišteková S, Kyzeková I, Ševčovičová A, Kováčik D, Zahoranová A, Gálová E.   +6 more
europepmc   +1 more source

m⁶A-driven transcriptomic rewiring in tumor immune surveillance. [PDF]

J Immunother Cancer
Malvi P, Ball P, Gupta R, Wajapeyee N.
europepmc   +1 more source

ADME analysis, metabolic prediction, and molecular docking of lipoic acid with SARS-CoV-2 Omicron spike protein. [PDF]

Sci Rep
Dos Santos CAL, de Araújo Monteiro AA, Costa AR, Barros LM, Aloufi A, Almutairi MM, Hassan W, Kamdem JP, Duarte AE, Ali A, Ibrahim M.   +10 more
europepmc   +1 more source

New insights in the mechanism of the SARS-CoV-2 M^pro inhibition by benzisoselenazolones and diselenides. [PDF]

Sci Rep
Sancineto L, Mangiavacchi F, Dabrowska A, Pacuła-Miszewska AJ, Obieziurska-Fabisiak M, Scimmi C, Ceccucci V, Kong J, Zhao Y, Ciancaleoni G, Nascimento V, Rizzuti B, Bortoli M, Orian L, Kula-Pacurar A, Yang H, Ścianowski J, Lei Y, Pyrc K, Santi C.   +19 more
europepmc   +1 more source

QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. [PDF]

Proc Natl Acad Sci U S A
Wei JR, Zhang B, Zhang Y, Chen WM, Zhang XP, Zeng TT, Li Y, Zhu YH, Guan XY, Li L.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular actions of Ebselen—an antiinflammatory antioxidant

General Pharmacology, 1995
1. Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is a non-toxic seleno-organic drug with antiinflammatory, antiatherosclerotic and cytoprotective properties. 2. Ebselen and some of its metabolites are effective reductants of hydroperoxides including those arising in biomembranes and lipoproteins. 3.
T Schewe
exaly   +3 more sources